# A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS

> **NCT02080377** · PHASE3 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 23 (actual)

## Conditions studied

- Pregnancy
- Gestational Diabetes

## Interventions

- **DRUG:** Glibenclamide
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT02080377
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-10
- **Final completion:** 2016-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080377, "A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02080377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*